The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
The renin-angiotensin-aldosterone system and its suppression
Open accessAbstract
Chronic activation of the renin-angiotensin-aldosterone system (RAAS) promotes and perpetuates the syndromes of congestive heart failure, systemic hypertension, and chronic kidney disease. Excessive circulating and tissue angiotensin II (AngII) and aldosterone levels lead to a pro-fibrotic, -inflammatory, and -hypertrophic milieu that causes remodeling and dysfunction in cardiovascular and renal tissues. Understanding of the role of the RAAS in this abnormal pathologic remodeling has grown over the past few decades and numerous medical therapies aimed at suppressing the RAAS have been developed. Despite this, morbidity from these diseases remains high. Continued investigation into the complexities of the RAAS should help clinicians modulate (suppress or enhance) components of this system and improve quality of life and survival. This review focuses on updates in our understanding of the RAAS and the pathophysiology of AngII and aldosterone excess, reviewing what is known about its suppression in cardiovascular and renal diseases, especially in the cat and dog.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–222 of 222
Hermida, R. C., Ayala, D. E., Mojón, A., & Fernández, J. R. (2015) · Diabetologia · doi:10.1007/s00125-015-3806-2 · Cited by 33
Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease
Ames, M. K., Atkins, C. E., Eriksson, A., & Hess, A. M. (2017) · Journal of Veterinary Cardiology · doi:10.1016/j.jvc.2017.03.001 · Cited by 33
Self-citationThe cardioprotective effects of mineralocorticoid receptor antagonists
van den Berg, T. N. A., Rongen, G. A. P. J. M., Fröhlich, G., Deinum, J., Hausenloy, D. J., & Riksen, N. P. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.006 · Cited by 32
Angiotensin II-aldosterone interactions on protein synthesis in vascular smooth muscle cells
Ullian, M. E., Hutchison, F. N., Hazen‐Martin, D. J., & Morinelli, T. A. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.6.c1525 · Cited by 31
Harada, K., Izawa, H., Nishizawa, T., Hirashiki, A., Murase, Y., Kobayashi, M., Isobe, S., Cheng, X. W., Noda, A., Nagata, K., et al. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181a717f7 · Cited by 29
Lantis, A. C., Ames, M. K., Atkins, C. E., DeFrancesco, T. C., Keene, B. W., & Werre, S. R. (2014) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12154 · Cited by 29
Self-citationMishina, M., & Watanabe, T. (2008) · Journal of Veterinary Medical Science · doi:10.1292/jvms.70.455 · Cited by 29
The prorenin receptor in the cardiovascular system and beyond
Hennrikus, M. T., González, A. A., & Prieto, M. C. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00373.2017 · Cited by 29
Miller, R. H., Lehmkuhl, L. B., Smeak, D. D., et al. (1999) · American Journal of Veterinary Research · doi:10.2460/ajvr.1999.60.12.1516 · Cited by 26
Big angiotensin-25: A novel glycosylated angiotensin-related peptide isolated from human urine
Nagata, S., Hatakeyama, K., Asami, M., Tokashiki, M., Hibino, H., Nishiuchi, Y., Kuwasako, K., Kato, J., Asada, Y., & Kitamura, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.124 · Cited by 25
Mello, W. C. D. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00072 · Cited by 22
Ames, M. K., Atkins, C. E., Lee, S., Lantis, A. C., & zumBrunnen, J. R. (2015) · American Journal of Veterinary Research · doi:10.2460/ajvr.76.12.1041 · Cited by 22
Self-citationEffect of spironolactone on diuresis and urine sodium and potassium excretion in healthy dogs
Jeunesse, É., Woehrlé, F., Schneider, M., et al. (2007) · Journal of Veterinary Cardiology · doi:10.1016/j.jvc.2007.10.002 · Cited by 21
The Epigenetic and Metabolic Language of the Circadian Clock
Sassone‐Corsi, P. (2016) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-27069-2_1 · Cited by 21
Lefebvre, H. P., Ollivier, E., Atkins, C. E., Combes, B., Concordet, D., Kaltsatos, V., & Baduel, L. (2013) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12141 · Cited by 20
Self-citationThe effect of enalapril on furosemide‐activated renin–angiotensin–aldosterone system in healthy dogs
Lantis, A. C., Ames, M. K., Werre, S. R., & Atkins, C. E. (2015) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12216 · Cited by 20
Self-citationSeeliger, E., Wronski, T., Wiegard, M., Rebeschke, T., Persson, P. B., & Reinhardt, H. W. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04201.x · Cited by 19
Geng, D.-F., Sun, W., Yang, L., En, G., & Wang, J. (2013) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320312474054 · Cited by 18
Meurs, K. M., Stern, J. A., Atkins, C. E., et al. (2017) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320317737184 · Cited by 16
Self-citationLee, J., Mizuno, M., Mizuno, T., Harada, K., & Uechi, M. (2015) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.13587 · Cited by 14
Thomason, J. D., Rapoport, G. S., Fallaw, T., & Calvert, C. A. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.09.004 · Cited by 6
Kawada, N., Isaka, Y., Kitamura, H., Rakugi, H., & Moriyama, T. (2014) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320314532509 · Cited by 3
Cited by
Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression
Naaman, S. C., & Bakris, G. L. (2023) · Diabetes Care · doi:10.2337/dci23-0030 · Cited by 292
Villaró, S., Jiménez-Márquez, S., Musari, E., Bermejo, R., & Lafarga, T. (2023) · Food Research International · doi:10.1016/j.foodres.2022.112270 · Cited by 50
Metadata
- Authors
- Ames, M. K., Atkins, C. E., & Pitt, B.
- Venue
- Journal of Veterinary Internal Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-03-01
- Volume
- 33
- Issue
- 2
- Pages
- 363-382
- ISSN
- 0891-6640 (ISSN-L)
- 1939-1676
- OpenAlex
- W2915506231
- Cited by
- 433
- References
- 222
- FWCI
- 28.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.